PwCs Appetite for Disruption: What GLP-1 Means for Consumer Markets report, based on a survey of more than 2,300 UK adults, shares insights on who is using GLP1s and how their behaviour is changing across six categories: food, alcohol, supplements, apparel, restaurants and fitness
Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies
What we can say is that trial reports have shown improvements in some cardiometabolic markers such as blood pressure, lipids and blood sugar, and Lilly is running dedicated phase 3 outcome studies including cardiovascular and renal outcomes
Dehydration risk represents another consideration
Ideal candidates are psoriasis patients with BMI 30 (or 27 with comorbidity), particularly those with suboptimal biologic response, metabolic syndrome, type 2 diabetes, established CVD, or MASH